Curia Global is an end-to-end Contract Research, Development and Manufacturing Organization (CRDMO) with expertise in biologics and small molecule drugs gained over decades serving pharmaceutical and biotechnology companies.

Our teams offer a comprehensive suite of services from discovery to manufacturing of mRNA therapeutics, including vector engineering, linearized plasmid production suitable for manufacturing, process development, drug substance manufacturing, lipid synthesis, LNP-mRNA formulation, drug product fill/finish, analytics and quality control assays. We have experience with both non-replicating and self-amplifying mRNAs and have synthesized molecules larger than 16 kb at scales ranging from milligram to multigram quantities.

Single-use technologies and animal component-free raw materials are important elements of our manufacturing processes. Our comprehensive suite of on-site analytics and quality control assays streamline process development and batch release. This seminar will cover all aspects of the manufacturing and analytical services described above.

In this webinar you’ll learn about Curia’s capabilities for:

• mRNA process development and manufacturing
• Lipid Synthesis
• LNP Formulation and Fill/Finish

Individuals that are interested in manufacturing services for mRNA therapeutics and vaccines